Roger Fine retired as corporate vice president and general counsel at Johnson & Johnson after 30 years, including 15 years on the Executive Committee, and now brings this rare large-company operating experience to early-stage healthcare investing at Windham Venture Partners. He simultaneously chairs the Robert Wood Johnson Foundation (the world's largest health-focused foundation) and runs an in-house venture fund that commercializes medical school discoveries, creating an unusual bridge between big pharma operations, major healthcare philanthropy, and venture capital. Roger Fine retired as corporate vice president and general counsel at Johnson & Johnson after 30 years, including 15 years on the Executive Committee, and now brings this rare large-company operating experience to early-stage healthcare investing at Windham Venture Partners. He simultaneously chairs the Robert Wood Johnson Foundation (the world's largest health-focused foundation) and runs an in-house venture fund that commercializes medical school discoveries, creating an unusual bridge between big pharma operations, major healthcare philanthropy, and venture capital.